$34.20
0.320.94%
Pre-Market: Jul 19, 5:12 PM EDT
15 minutes delayed
Comments
Loading...
Corcept Therapeutics
CORTNASDAQ
Corcept Therapeutics (CORT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Corcept Therapeutics (NASDAQ:CORT) Stock Quotes, Forecast and News Summary
Corcept Therapeutics Stock (NASDAQ: CORT) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 1.17M |
| Day Range | - - - |
| 52 Wk Range | 20.84 - 35.22 |
| Market Cap | $3.56B |
| P/E Ratio | 32.27 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 67 |
| Short Interest | 29.59% |
| Days to Cover | 19.71 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Corcept Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and d...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Corcept Therapeutics (CORT) stock?
You can purchase shares of Corcept Therapeutics (NASDAQ:CORT) through any online brokerage.
Who are Corcept Therapeutics (CORT) competitors?
Other companies in Corcept Therapeutics’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
What is the target price for Corcept Therapeutics (CORT) stock?
There is no analysis for Corcept Therapeutics.
What is the forecast for Corcept Therapeutics (CORT) stock?
Corcept Therapeutics has a consensus price target of $35.50.
Current stock price for Corcept Therapeutics (CORT)?
The stock price for Corcept Therapeutics (NASDAQ: CORT) is $34.2 last updated July 19, 2024 at 5:12 PM EDT.
Does Corcept Therapeutics (CORT) pay a dividend?
There are no upcoming dividends for Corcept Therapeutics.
When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?
Corcept Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is Corcept Therapeutics (CORT) going to split?
There is no upcoming split for Corcept Therapeutics.
What sector and industry does Corcept Therapeutics (CORT) operate in?
Corcept Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.